{
    "clinical_study": {
        "@rank": "41813", 
        "acronym": "NUTRI_REA", 
        "arm_group": [
            {
                "arm_group_label": "Sondalis\u00ae HP", 
                "arm_group_type": "Active Comparator", 
                "description": "The Control Group that will receive Sondalis \u00ae HP (a whole-peptide formula)."
            }, 
            {
                "arm_group_label": "Peptamen\u00ae AF", 
                "arm_group_type": "Experimental", 
                "description": "In this arm, patients have enteral nutrition with Peptamen\u00ae AF"
            }
        ], 
        "brief_summary": {
            "textblock": "An early and efficient enteral nutritional support could improve the clinical outcomes of\n      brain injured critically ill patients. Gastrointestinal feeding intolerance defined as an\n      increased gastric residual volume frequently occurs in these patients.\n\n      Previous experimental studies have suggested that a small-peptide enteral feeding formula\n      could promote the gastric emptying compared to a whole-protein formula. An improved\n      gastrointestinal tolerance of enteral nutrition should allow a rapid increase in the daily\n      caloric intake and enhance nutritional support of brain injured critically ill patients."
        }, 
        "brief_title": "Efficiency of a Small-peptide Enteral Feeding Formula Compared to a Whole-protein Formula", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Traumatic and/or Non-traumatic Brain Injury", 
            "Critically Ill"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Critical Illness", 
                "Brain Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "This open-labelled prospective randomized trial aims to compare 2 groups of patients: the\n      Study Group and the Control Group. The randomization process will concern the allocation of\n      the type of enteral feeding formula administered for nutritional support: Peptamen\u00ae AF in\n      the Study Group, and Sondalis\u00ae HP in the Control Group. 2 centers are involved in this\n      study.\n\n      Each patient admitted in the critical care unit will be assessed for eligibility. After\n      written informed consent is obtained from relatives, patient without any exclusion criteria\n      will be included in the study.\n\n      The allocation of the type of enteral nutritional feeding formula will be randomized after\n      inclusion.\n\n      Enteral nutrition according to the randomization group will start within the 48 hours of\n      admission and up to 10 days, if requested. Beyond the 10th day, all patients will receive\n      standard enteral nutrition formula.\n\n      After inclusion, data regarding efficacy and tolerance will be assessed daily up to day 10.\n\n      Mortality and outcome will be assessed at day 28 and at day 60."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Admission in our surgical critical care unit.\n\n          -  Traumatic brain injury.\n\n          -  Non-traumatic brain injury: stroke, intracranial and/or subarachnoid hemorrhage,\n             subdural and/or extradural hematoma.\n\n          -  Expected duration of mechanical ventilation > 48 hours.\n\n        Exclusion Criteria:\n\n          -  Abdominal surgery in the previous 30 days.\n\n          -  Pregnancy.\n\n          -  Breast-feeding.\n\n          -  Hemodynamic instability defined as infusion of norepinephrine > 3 mg/h, or\n             epinephrine > 1 mg/h, or as increasing needs in vasopressive or inotropic drugs."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "206", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01833624", 
            "org_study_id": "2012-A00078-35"
        }, 
        "intervention": [
            {
                "arm_group_label": "Sondalis\u00ae HP", 
                "description": "Comparison of two types of enteral nutrition feeding: Peptamen\u00ae AF and Sondalis\u00ae HP", 
                "intervention_name": "Peptamen\u00ae AF", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Peptamen\u00ae AF", 
                "intervention_name": "Sondalis\u00ae HP", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 16, 2013", 
        "location": {
            "contact": {
                "email": "annesophie.balon@gmail.com", 
                "last_name": "Anne-Sophie BALON", 
                "phone": "+3381668675"
            }, 
            "facility": {
                "address": {
                    "city": "Besan\u00e7on", 
                    "country": "France", 
                    "zip": "25030"
                }, 
                "name": "Surgical Critical Care Unit, CHRU Jean Minjoz"
            }, 
            "investigator": {
                "last_name": "Gilles Blasco", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficiency and Tolerance of a Small-peptide Enteral Feeding Formula Compared to a Whole-protein Formula in the Critically Ill Patient : a Prospective Randomized Trial", 
        "overall_contact": {
            "email": "annesophie.balon@gmail.com", 
            "last_name": "Anne-Sophie BALON", 
            "phone": "+3381668675"
        }, 
        "overall_official": {
            "last_name": "Gilles Blasco", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To compare the nutritional efficacy of a small-peptide (Peptamen AF\u00ae) to that of a whole-protein (Sondalis HP\u00ae) enteral feeding formula in traumatic and non-traumatic brain injured critically ill patients.", 
            "measure": "the nutritional efficacy of a small-peptide (Peptamen AF\u00ae) to that of a whole-protein (Sondalis HP\u00ae) enteral feeding formula in traumatic and non-traumatic brain injured critically ill patients", 
            "safety_issue": "No", 
            "time_frame": "Day3 to Day5"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01833624"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre Hospitalier Universitaire de Besancon", 
            "investigator_full_name": "Anne-Sophie BALON", 
            "investigator_title": "Docteur Anne-Sophie BALON", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "impact on morbidity and mortality of a small-peptide (Peptamen AF\u00ae) to that of a whole-protein (Sondalis HP\u00ae) enteral feeding formula.", 
            "safety_issue": "No", 
            "time_frame": "Day 10"
        }, 
        "source": "Centre Hospitalier Universitaire de Besancon", 
        "sponsors": {
            "collaborator": {
                "agency": "Nestl\u00e9 Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de Besancon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}